http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c892cbe719fdbd9c08f179a759e7c77
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Naoe |
| name | Tomoki Naoe |
| given-name | Tomoki |
| organization-name | Subcommittee on Nonâclinical Studies The Science Board to the Pharmaceuticals and Medical Devices Agency Tokyo Japan; National Hospital Organization Nagoya Medical Center Nagoya Japan From the Department of Chemotherapy, Saitama Cancer Center Research Institute, Saitama, Japan; the Institute for Virus Research, Kyoto University, Kyoto, Japan; the Faculty of Pharmaceutical Sciences, University of Tokyo, Tokyo, Japan; the Department of Infectious Diseases, Nagoya University School of Medicine, Nagoya, Japan; and the First Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan. From the Department of Medicine, Nagoya University Branch Hospital, Higashi-ku, Nagoya; the First Department of Internal Medicine, Nagoya University School of Medicine, Showa-ku, Nagoya; Japanese Red Cross Aichi Blood Center, Seto, Aichi; Veterans Affairs Medical Center, Hematology/Oncology, Houston, Texas; the Department of Central Clinical Laboratory, Meijo Hospital, Naka-ku, Nagoya; and the Department of Gynecology, Handa Municipal Hospital, Handa, Japan. From the Department of Hematology and Oncology, Nagoya University Graduate School of Medicine; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital; Department of Pathology and Clinical Laboratories, Nagoya University Hospital, Nagoya; Division of Hematology/Oncology, Kameda General Hospital, Kamogawa; Department of Internal Medicine, Nishio Municipal Hospital, Nishio; First Department of Internal Medicine, Nagano Red Cross Hospital, Nagano; Department of Medicine, Fujita-Health... Department of Hematology and Oncology Nagoya University Graduate School of Medicine Aichi Japan Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Katsuji Shinagawa, Okayama University Hospital, Okayama; Masamitsu Yanada and Nobuhiko Emi, Fujita Health University School of Medicine, Toyoake; Toru Sakura, Saiseikai Maebashi Hospital, Maebashi; Yasunori Ueda, Kurashiki Central Hospital, Kurashiki; Masashi Sawa, Anjo Kosei Hospital, Anjo; Junichi Miyatake, Kinki University Faculty of Medicine, Osakasayama; Nobuaki Dobashi, Jikei University School of Medicine; Yoshihiro Hatta, Nihon University School of Medicine; Yukio Kobayashi, National Cancer Center... 4Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan National Hospital Organization Nagoya Medical Center Nagoya Aichi Japan 6National Hospital Organization Nagoya Medical Center, Nagoya, Japan Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Hematology/Oncology Research, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan Nagoya Medical Center National Hospital Organization Nagoya Japan From the Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu; the Department of Infectious Diseases, Nagoya University School of Medicine, Nagoya; the Department of Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka; the Department of Medicine, National Minami-Okayama Hospital, Okayama; the Department of Medicine, Saiseikai Maebashi Hospital, Maebashi; and the Department of Medicine, Nagoya City University School of Medicine, Nagoya, Japan. National Hospital Organization Nagoya Medical Center, Nagoya, Japan From the Department of Cardiovascular Genome Science (J.X., K.O., M.Y.), Nagoya University School of Medicine, Japan; Department of Molecular Medicine and Clinical Science (J.X., T. Naoe), Department of Cardiology (H.I., T.M.), and Department of Clinical Pathophysiology (T. Nagasaka), Nagoya University Graduate School of Medicine, Japan; Nagoya University School of Health Sciences (K.N., A.N.), Japan; Life Science Research Center (S.I.), Mie University, Tsu, Japan; and Toyota Memorial Hospital (M.I.... Department of Hematology and Oncology Nagoya University Graduate School of Medicine Nagoya Nagoya University Graduate School of Medicine Nagoya Japan 3Department of Molecular Medicine and Clinical Science, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan Department of Hematology and Oncology, Graduate School of Medicine, Nagoya University, Showa-ku, Nagoya, Japan. Department of Infectious Diseases; Nagoya University School of Medicine; Nagoya, Japan Department of Hematology and Oncology, Nagoya University Graduate School of Medicine National Hospital Organization Nagoya Medical Center Nagoya Japan Department of Hematology National Hospital Organization Nagoya Medical Center Nagoya Japan National Hospital Organization Nagoya Medical Center , Aichi , Japan Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; and Department of Hematology and Oncology Nagoya University Graduate School of Medicine Nagoya Japan Nagoya Medical Center Nagoya Japan *Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan;; **National Hospital Organization Nagoya Medical Center, Nagoya 460-0001, Japan 5Department of Hematology, Nagoya University Graduate School of Medicine, and Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Japan National Hospital Organization Nagoya Medical Center, Nagoya, Japan; From the Departments of Transfusion Medicine (K.Y., S.S., J.T.), Cardiology (T.K., H.I., T.M.), Vascular Surgery (M.K., K.K.), and Hematology (N.E., T.N.), Nagoya University Hospital, Nagoya, Japan. National Hospital Organization Nagoya Medical Center Aichi Japan Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan; National Hospital Organization Nagoya Medical Center, Nagoya, Japan Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya; Department of Medicine, Nagoya University School of Medicine Branch Hospital, Nagoya, Japan, JP 3Nagoya University, Nagoya, Japan; Department of Hematology, Nagoya University Graduate School of Medicine *Department of Hematology and Oncology, Graduate School of Medicine, Nagoya University, Nagoya, 466-8550, Japan; and Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan Nagoya University Graduate School of Medicine Nagoya Japan; National Hospital Organization Nagoya Medical Center Nagoya Japan National Hospital Organization Nagoya Medical Center, Nagoya, Japan. Department of Hematology/Oncology Nagoya University Graduate School of Medicine Nagoya Japan Department of Hematology, Nagoya University, Graduate School of Medicine Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Aichi, Japan; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan ; National Hospital Organization Nagoya Medical Center, Nagoya, Japan. Department of Hematology/Oncology, Nagoya University Graduate School of Medicine, Japan; Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan; From the Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Japan; the Department of Infectious Diseases, Nagoya University School of Medicine, Nagoya, Japan; the Second Department of Internal Medicine, Nagoya City University School of Medicine, Nagoya, Japan; and the Department of Medicine, Nagoya National Hospital, Nagoya, Japan. Nagoya University, Nagoya, Japan; National Hospital Organization Nagoya Medical Center, Nagoya, Japan; and Authors' Affiliations: 1First Department of Internal Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo; 2Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya; 3Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga; and 4Department of Transfusion Medicine and Cell Therapy, Kyoto University Hospital, Faculty of Medicine, Kyoto University, Kyoto, Japan Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan; Department of Hematology and Oncology Nagoya University Graduate School of Medicine Nagoya Japan; National Hospital Organization Nagoya Medical Center Nagoya Japan Department of Hematology and Oncology Nagoya University Graduate School of Medicine Nagoya Japan; Department of Hematology/Oncology Research Clinical Research Center National Hospital Organization Nagoya Medical Center Nagoya Japan 6Japan Adult Leukemia Study Group, Japan; 23Nagoya Medical Center, Aichi, Japan Hematology and Oncology Department, Graduate School of Medicine, Nagoya University, Nagoya, Japan |
Incoming Links
Total number of triples: 417.